Incorporating genetic potential when evaluating stature in children with cystic fibrosis

Zhumin Zhang1, Suzanne M Shoff, Huichuan J Lai

  • 1Department of Nutritional Sciences, University of Wisconsin, Madison, Wisconsin, United States.

Insights

Adjusting for genetic potential is crucial for accurately assessing short stature in children with cystic fibrosis (CF). Failure to do so underestimates prevalence and biases lung function correlations.

Area of Science:

  • Pediatric endocrinology
  • Genetics
  • Pulmonology

Background:

  • The Cystic Fibrosis Foundation (CFF) guidelines recommend adjusting for genetic potential when evaluating height in children with CF.
  • Limited data currently support this recommendation.
  • Accurate height assessment is vital for monitoring growth and health outcomes in pediatric CF patients.

Purpose of the Study:

  • To compare different methods of classifying short stature in children with cystic fibrosis (CF).
  • To evaluate the impact of adjusting for genetic potential on short stature prevalence and its association with lung function.

Main Methods:

  • Analysis of data from 3306 children with CF and documented parental heights from the 1986-2005 CFF Patient Registry.
  • Comparison of three classification methods: unadjusted height percentile <10th, Himes adjusted height percentile <10th, and unadjusted height below CFF target lower bound.

Main Results:

  • Children with CF had lower height percentiles than their parents.
  • Himes adjustment significantly altered height percentile classification, particularly in children with short or tall parents.
  • Prevalence of short stature varied substantially based on the classification method used.
  • Himes adjustment revealed a stronger positive association between height percentile and lung function (percent predicted FEV1).

Conclusions:

  • Failure to adjust for genetic potential leads to underestimation of short stature prevalence in children with CF.
  • Unadjusted height assessments can bias the observed relationship between height and lung function.
  • Adjusting for genetic potential provides a more accurate evaluation of growth status in pediatric CF patients.
Abstract

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Gene-Environment Interactions01:20

Gene-Environment Interactions

Gene expression is a dynamic process that is significantly influenced by environmental factors. This interaction underlies the complex nature of biological development and the phenotypic differences observed among individuals, even among those with identical genetic makeups. Factors such as radiation, temperature, behavior, nutrition, and stress play pivotal roles in determining how genes are expressed. The concept of the reaction range is central to understanding this interaction. It posits...
What is Genetic Engineering?00:49

What is Genetic Engineering?

Overview